Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:TARO

Taro Pharmaceutical Industries (TARO) Stock Price, News & Analysis

Taro Pharmaceutical Industries logo

About Taro Pharmaceutical Industries Stock (NYSE:TARO)

Advanced Chart

Key Stats

Today's Range
$42.97
$42.97
50-Day Range
$42.20
$42.99
52-Week Range
$32.67
$45.76
Volume
N/A
Average Volume
45,199 shs
Market Capitalization
$1.62 billion
P/E Ratio
29.84
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive TARO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Taro Pharmaceutical Industries and its competitors with MarketBeat's FREE daily newsletter.

TARO Stock News Headlines

A new rule goes live in July — and the banks are quietly cashing in
A major change is quietly going into effect this July — and Wall Street is already positioning for it. Big Banks have found a way to use a new asset as if it were cash. Not stocks. Not bonds. Not even the U.S. dollar. They now trust this asset more than the traditional financial system itself.
See More Headlines

TARO Stock Analysis - Frequently Asked Questions

Taro Pharmaceutical Industries Ltd. (NYSE:TARO) issued its quarterly earnings data on Thursday, October, 28th. The company reported $0.66 earnings per share for the quarter, missing the consensus estimate of $1.02 by $0.36. The business had revenue of $131.99 million for the quarter, compared to the consensus estimate of $153.23 million. Taro Pharmaceutical Industries had a net margin of 8.56% and a trailing twelve-month return on equity of 3.75%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Taro Pharmaceutical Industries investors own include NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), Advanced Micro Devices (AMD), Adobe (ADBE), ServiceNow (NOW) and Arista Networks (ANET).

Company Calendar

Last Earnings
10/28/2021
Today
7/14/2025
Fiscal Year End
3/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NYSE:TARO
CIK
906338
Employees
1,554
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
$1.44
Trailing P/E Ratio
29.84
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$53.87 million
Net Margins
8.56%
Pretax Margin
13.14%
Return on Equity
3.75%
Return on Assets
3.09%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
3.61
Quick Ratio
3.04

Sales & Book Value

Annual Sales
$629.18 million
Price / Sales
2.57
Cash Flow
$2.38 per share
Price / Cash Flow
18.03
Book Value
$47.70 per share
Price / Book
0.90

Miscellaneous

Outstanding Shares
37,590,000
Free Float
32,400,000
Market Cap
$1.62 billion
Optionable
Optionable
Beta
0.56
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NYSE:TARO) was last updated on 7/14/2025 by MarketBeat.com Staff
From Our Partners